Researchers have unveiled a new test that can identify the deadly tick-borne disease Rocky Mountain spotted fever in just 40 minutes, a speed that could enable faster treatment and improve patient outcomes.
How the rapid test works
The assay relies on a two‑step process, each lasting about 20 minutes, that mixes DNA extracted from a blood sample with specialized reagents. The reaction proceeds at room temperature, eliminating the need for costly thermal cyclers or other sophisticated lab equipment. When the target bacterial DNA is present, a visible color change occurs in the liquid, signaling a positive result.
Current diagnostic methods for the disease often require expensive instruments and can miss low levels of bacterial DNA, leading to delayed or missed diagnoses. By simplifying the workflow, the new test offers a practical alternative for clinics that lack advanced molecular capabilities.
Related: Eye chart test may not be enough
Potential impact on treatment
Early detection is essential because patients can progress from a tick bite to severe fever, headache, and rash within days. The antibiotic doxycycline is the standard therapy, and clinicians frequently prescribe it empirically while awaiting confirmatory results. Existing testing timelines can be too slow to guide timely decisions.
“This disease can be particularly deadly in children if diagnosis is delayed, and often patients may not realize they have been bitten by a tick until they feel extremely ill,” said Roman Ganta, a professor at the College of Veterinary Medicine and lead investigator on the study. “Quicker diagnosis leads to quicker treatment with doxycycline, so we are hopeful our research can improve outcomes for those impacted.”
Ganta envisions the assay being deployed in rural or under‑resourced clinics worldwide, where access to high‑end laboratory tools is limited. He is currently discussing implementation possibilities with the Veterinary Medical Diagnostic Laboratory at the university, aiming to move the test from the research bench toward clinical use.
Implementation could save lives.
Related: User Receives Unexpected Block Notification
When compared to earlier rapid‑diagnostic efforts for other vector‑borne illnesses, this development stands out for its combination of speed, simplicity, and low equipment requirements. Earlier tools often still needed a small incubator or specialized lighting, which can be a barrier in field settings. The new method’s room‑temperature operation could therefore broaden the range of locations where reliable testing is feasible.
The research appears in Frontiers in Microbiology, adding to a growing body of work that seeks to make molecular diagnostics more accessible. While the assay still requires validation in larger patient cohorts, its initial performance suggests it could fill a gap in the current diagnostic setting.
As the study moves toward potential clinical adoption, health officials may consider integrating the test into existing protocols for suspected cases, especially in regions where the disease is endemic and laboratory resources are scarce. If successful, the approach could set a precedent for rapid detection of other tick‑borne pathogens.